Oxford, United Kingdom · Founded 2014 · Privately Held (backing)
Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. Genomics is based in Oxford, United Kingdom and was founded in 2014. Its last known valuation is $162 million. It has raised $142 million.
Last price · $/share
—
Implied valuation
$161.6M
Total raised
$142.2M
Last round
—
Cap table — not yet on record
Genomics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genomics with a free account
·The complete investor list: 16 names
·Watch Genomics: the Monday email on marks, rounds and moves
